MA
Md Amir Ali Khan
About Md Amir Ali Khan
Data last updated:
Md Amir Ali Khan is a Director at Riffa Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Riffa Pharmaceuticals Private Limited reported revenue of ₹8.4 Lakh (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Jul 2020 | 2016 | ₹8.4 Lakh (FY 2017) | Active |
Board colleagues of Md Amir Ali Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rambadan Paswan | 07465909 | Riffa Pharmaceuticals Private Limited | Director |
| Saba Nazim | 08809836 | Riffa Pharmaceuticals Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Md Amir Ali Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Md Amir Ali Khan
Md Amir Ali Khan currently holds 1 directorship: Riffa Pharmaceuticals Private Limited (Director, since 29 Jul 2020, revenue ₹8.4 Lakh (FY 2017)).
Md Amir Ali Khan was first appointed on 29 Jul 2020 as Director at Riffa Pharmaceuticals Private Limited.
The current boards of Md Amir Ali Khan's companies include Rambadan Paswan (Riffa Pharmaceuticals Private Limited), Saba Nazim (Riffa Pharmaceuticals Private Limited).